We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current DXRX market cap is 110.13M. The company's latest EPS is GBP -0.0206 and P/E is -63.11.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 13.44M | 12.7M | 13.94M | 19.5M | 23.7M |
| Operating Income | 740k | -716k | 550k | 575k | -3.02M |
| Net Income | 398k | 263k | 561k | 724k | -1.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 22.37M | 43.52M | 45.01M | 48.26M | 46.34M |
| Total Liabilities | 2.24M | 3.28M | 4.36M | 5.74M | 5.56M |
| Total Equity | 20.13M | 40.24M | 40.65M | 42.51M | 40.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -630k | 253k | 570k | 5.1M | 1.31M |
| Investing | -2.92M | -6.29M | -5.6M | -4.76M | -4.21M |
| Financing | 13.29M | 19.61M | -270k | -191k | -239k |
| Market Cap | 110.13M |
| Price to Earnings Ratio | -63.11 |
| Price to Sales Ratio | 4.65 |
| Price to Cash Ratio | 6.61 |
| Price to Book Ratio | 2.7 |
| Dividend Yield | - |
| Shares Outstanding | 84.71M |
| Average Volume (1 week) | 56.2k |
| Average Volume (1 Month) | 74.61k |
| 52 Week Change | 34.72% |
| 52 Week High | 136.00 |
| 52 Week Low | 82.50 |
| Spread (Intraday) | 2 (1.53%) |
| Company Name | Diaceutics Plc |
| Address |
first floor, building two belfast BT9 6GW |
| Website | https://www.diaceutics.com |
| Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
